Sage Therapeutics, Inc. Operating Margin in % from 2018 to Q2 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sage Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2018 to Q2 2025.
  • Sage Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2025 was -461 %, a 7.1% increase year-over-year.
  • Sage Therapeutics, Inc. annual Operating Margin for 2024 was -1.05K %, a 56.3% decline from 2023.
  • Sage Therapeutics, Inc. annual Operating Margin for 2023 was -671 %, a 90.6% increase from 2022.
  • Sage Therapeutics, Inc. annual Operating Margin for 2022 was -7.12K %, a 2.6% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Sage Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -461 +35.3 +7.1% Apr 1, 2025 Jun 30, 2025
Q1 2025 -806 -211 -35.4% Jan 1, 2025 Mar 31, 2025
Q4 2024 -1.05K -378 -56.3% Oct 1, 2024 Dec 31, 2024
Q3 2024 -350 +5.75K +94.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -497 +5.49K +91.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -595 +5.57K +90.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -671 +6.45K +90.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -6.1K +1.93K +24% Jul 1, 2023 Sep 30, 2023
Q2 2023 -5.99K +2.25K +27.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -6.16K +1.57K +20.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -7.12K +190 +2.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -8.02K -8.08K -14094% Jul 1, 2022 Sep 30, 2022
Q2 2022 -8.24K -8.3K -13960% Apr 1, 2022 Jun 30, 2022
Q1 2022 -7.73K -7.79K -13735% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.31K -7.36K -13755% Oct 1, 2021 Dec 31, 2021
Q3 2021 57.3 +7.98K Jul 1, 2021 Sep 30, 2021
Q2 2021 59.5 +7.16K Apr 1, 2021 Jun 30, 2021
Q1 2021 56.7 +7.77K Jan 1, 2021 Mar 31, 2021
Q4 2020 53.5 +10.4K Oct 1, 2020 Dec 31, 2020
Q3 2020 -7.92K +5.55K +41.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -7.1K Apr 1, 2020 Jun 30, 2020
Q1 2020 -7.71K Jan 1, 2020 Mar 31, 2020
Q4 2019 -10.3K Oct 1, 2019 Dec 31, 2019
Q3 2019 -13.5K Jul 1, 2019 Sep 30, 2019

Sage Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1.05K -378 -56.3% Jan 1, 2024 Dec 31, 2024
2023 -671 +6.45K +90.6% Jan 1, 2023 Dec 31, 2023
2022 -7.12K +190 +2.6% Jan 1, 2022 Dec 31, 2022
2021 -7.31K -7.36K -13755% Jan 1, 2021 Dec 31, 2021
2020 53.5 +10.4K Jan 1, 2020 Dec 31, 2020
2019 -10.3K -9.87K -2267% Jan 1, 2019 Dec 31, 2019
2018 -436 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.